t
Oxford Biomedica PLC filed Block Listing Returns on 04 January 2022 for four employee share schemes, covering the period from 1 July 2021 to 31 December 2021. During this six-month period, the company issued a total of 200,301 securities across these schemes. As of 31 December 2021, a total of 917,468 securities remained unallotted under the 2015 Employee Share Option Scheme, 2015 Long Term Incentive Plan, 2015 Deferred Bonus Plan, and Sharesave Scheme.
| Date | 4 Jan 2022 |
| Time | 11:07:19 |
| Category | Capital structure |
| ID | 3662X |
|
For Immediate Release |
04 January 2022 |
OXFORD BIOMEDICA PLC
BLOCK LISTING RETURN
|
Name of applicant: |
OXFORD BIOMEDICA PLC |
|||
|
Name of scheme: |
2015 Employee Share Option Scheme |
|||
|
Period of return: |
From: |
1 July 2021 |
To: |
31 December 2021 |
|
Balance of unallotted securities under scheme(s) from previous return: |
256,544 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
NIL |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
114,586 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
141,958 |
|||
|
Name of applicant: |
OXFORD BIOMEDICA PLC |
|||
|
Name of scheme: |
2015 Long Term Incentive Plan |
|||
|
Period of return: |
From: |
1 July 2021 |
To: |
31 December 2021 |
|
Balance of unallotted securities under scheme(s) from previous return: |
258,468 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
NIL |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
30,088 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
228,380 |
|||
|
Name of applicant: |
OXFORD BIOMEDICA PLC |
|||
|
Name of scheme: |
2015 Deferred Bonus Plan |
|||
|
Period of return: |
From: |
1 July 2021 |
To: |
31 December 2021 |
|
Balance of unallotted securities under scheme(s) from previous return: |
226,888 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
NIL |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
20,053 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
206,835 |
|||
|
Name of applicant: |
OXFORD BIOMEDICA PLC |
|||
|
Name of scheme: |
Sharesave Scheme |
|||
|
Period of return: |
From: |
1 July 2021 |
To: |
31 December 2021 |
|
Balance of unallotted securities under scheme(s) from previous return: |
375,869 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
NIL |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
35,574 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
340,295 |
|||
|
Name of contact: |
Natalie Walter |
|
Telephone number of contact: |
01865 783000 |